News
6 things to know about lenacapavir, what experts call a ‘wonder drug’ for preventing HIV
The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts say lenacapavir is easier to administer, and each dose lasts longer compared to other medications.
Everyday Health on MSN1h
FDA Approves a ‘Game-Changing’ Twice-a-Year HIV Prevention ShotThe new HIV PrEP option could drastically reduce the number of new cases by offering a new alternative to daily pills or every-other-month injections.
Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.
IFLScience on MSN6h
Revolutionary Drug That's “Closest Thing” To HIV Vaccine Gets FDA ApprovalThe Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that has been shown to act as ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
Although largely as expected by investors, BMO Capital says lenacapavir’s approval for prevention, now known as Yeztugo, marks “a major win for Gilead (GILD)” in driving meaningful growth in its ...
HIV and global health activists say the deployment of Gilead’s twice-a-year HIV prevention shot is the world’s best chance to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback